Clinical Study

Rivastigmine as a Symptomatic Treatment for Apathy in Parkinson’s Dementia Complex: New Aspects for This Riddle

Table 3

Baseline NPI results.

Subitems NPINumber of patients/48 (%)Frequency × severityCaregiver distress

hallucinations20 (42%)21
Delusions10 (21%)11
Agitation/aggression5 (10%)21
Dysphoria/depression22 (46%)42
Anxiety26 (54%)62
Irritability7 (15%)42
Disinhibition2 (4%)22
Euphoria3 (6%)22
Apathy37 (77%)84
Aberrant motor behavior3 (6%)22
Sleep behavior change6 (12%)43
Appetite change2 (4%)22